Opus Genetics (IRD) Non-Current Assets (2010 - 2026)
Opus Genetics' (IRD) quarterly Non-Current Assets came in at $186000.0 in Q1 2026, down 22.18% year-on-year from $239000.0 in Q1 2025, and down 6.53% on a QoQ basis from $199000.0 in Q4 2025.
Opus Genetics (IRD) Non-Current Assets (2010 - 2026) Analysis & Trends
Opus Genetics (IRD) has 17 years of Non-Current Assets data on file, last reported at $186000.0 in Q1 2026.
- On a quarterly basis, Non-Current Assets fell 22.18% year-over-year to $186000.0 in Q1 2026; TTM through Mar 2026 was $823000.0, a 67.62% increase from a year earlier, with the FY2025 full-year figure at $199000.0, down 21.03% from the prior year.
- Non-Current Assets for Q1 2026 stood at $186000.0, down from $199000.0 in the prior quarter.
- Over the last five years, Non-Current Assets for IRD reached as high as $252000.0 in Q4 2024 and fell as low as $3000.0 in Q3 2023.
- Historically, Non-Current Assets has averaged $104307.7 across 5 years, with a median of $9000.0 in 2022.
- Across the five-year window, Non-Current Assets sank 57.14% in 2023 and dropped 21.03% in 2025, its largest moves.
- Year by year, Non-Current Assets stood at $6000.0 in 2022, then slumped by 50.0% to $3000.0 in 2023, then jumped by 8300.0% to $252000.0 in 2024, then slipped by 21.03% to $199000.0 in 2025, then decreased by 6.53% to $186000.0 in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $186000.0 in Q1 2026, $199000.0 in Q4 2025, and $212000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | Opus Genetics | 3.27 Mn | -56.73 Mn | - | 186,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 186,000.00 |
| Dec 31, 2025 | 199,000.00 |
| Sep 30, 2025 | 212,000.00 |
| Jun 30, 2025 | 226,000.00 |
| Mar 31, 2025 | 239,000.00 |
| Dec 31, 2024 | 252,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | 5,000.00 |
| Dec 31, 2022 | 6,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Jun 30, 2022 | 8,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Sep 30, 2021 | 11,000.00 |
| Jun 30, 2021 | 12,000.00 |
| Mar 31, 2021 | 13,000.00 |
| Dec 31, 2020 | 14,000.00 |
| Sep 30, 2020 | 180,564.00 |
| Jun 30, 2020 | 222,470.00 |